can semaglutide cause mental health issues GLP-1 and Depression Risk: Effects Explained An analysis on the role

A race for MASH drug development Resmetirom (Rezdiffra), a liver-targeted THR- receptor agonist, marked the first major milestone in drug development for MASH

Tesamorelin GHRH Analog Benefits Beyond Visceral Fat Visceral fat reduction is the headline but not the only effect

However, treatment-related muscle loss and weight regain after discontinuation have been reported, highlighting the need for further research to elucidate the potential adverse effects associated with long-term use.[7] Sarcopenia is defined as the loss of skeletal muscle mass and function, most commonly observed in older adults.[8] In contrast, obesity is diagnosed in individuals with a body mass index of 30 kg/m 2 or higher and can occur across all age groups

But now there's a new option: oral semaglutide, which is available as a daily tablet